1. Introduction
Molecular cages are supramolecular structures that can isolate guest molecules from the surrounding media by encapsulation in their central cavity, mimicking the encapsulation processes found in biological systems [
1,
2,
3]. In fact, in biology compartmentalization has a vital importance in keeping the living organisms away from equilibrium, resulting in a complex network of non-equilibrium chemical systems [
4]. Molecular cages are therefore suitable systems for mimicking these complex functions. The three-dimensional shape of their cavity gives a unique preorganization with enhanced affinity for guests in comparison to related supramolecular architectures such as macrocycles [
5,
6]. This property makes cages unique species for diverse applications such as catalysis [
7,
8,
9,
10,
11], sensing of diverse chemical species [
12,
13,
14,
15,
16,
17,
18,
19], separation of chemicals [
20,
21,
22,
23,
24], removal of pollutants from water [
25,
26,
27,
28], stabilization of chemical species [
29,
30], biological applications [
31,
32,
33,
34,
35,
36,
37,
38,
39,
40], and many others [
1,
2]. In addition to these properties, molecular cages can be engineered to transport cargo molecules [
41] with stimuli-responsive properties to pH [
34,
42,
43] and light [
44,
45,
46,
47], among others [
48,
49,
50,
51,
52,
53,
54]. Typically, cages are prepared by the thermodynamically controlled self-assembly of metals and ligands to yield metallo-cages or by the self-assembly of only organic ligands to yield pure organic cages [
1,
2,
55,
56,
57]. To facilitate the design of cages with specific geometries and properties, computational modelling has been extensively used. This allows reducing trial-and-error attempts or predict host-guest properties [
58,
59,
60,
61,
62,
63,
64].
Focusing on therapeutic applications of molecular cages, cages are capable of encapsulating drugs, forming inactive guest⊂cage complexes, in which the activity of the drug is restored upon their release from the cage [
31,
32]. In this area, it is crucial to design cages that efficiently encapsulate drugs and respond to selective stimuli for controlled drug release [
34,
65,
66]. Various systems have been developed for this purpose, most of which rely on equilibrium processes, which present limitations related to dynamic equilibria and drug dissociation when applied in a physiological environment [
1,
2]. Achieving systems where drugs are kinetically trapped inside the cage, is a challenging task. To accomplish this, the constrictive binding strategy has been proposed in simple host–guest systems, where the guest in–out activation barrier prevents rapid equilibrium between the drug inside the cavity and the external environment. The in-and-out passage of the guest molecule requires heating to widen the portals to create sufficient space [
67].
Cram, back in 1991, reported an example of constrictive binding of a 1,1,2,2-tetrachloroethane guest molecule using a fully organic hemicarcerand host [
68]. This guest⊂cage complex is stable at room temperature in the solid state or in solution, but slowly decomplexes by heating it at 100–134 °C. The van’t Hoff analysis provided an activation barrier of 24.6 kcal/mol, with a
t1/2 value of 18 h at 100
oC. Further studies by Cram showed that the in–out activation barriers are guest-dependent for a series of hemicarcerands, with the larger guests found to have lower activation energies for decomplexing. This is likely due to an increased compression of the cage to accommodate them, which are released upon decomplexation [
69]. The relative size of the guest regarding the size of the portals of the cage is a key parameter for successful constrictive binding. If the guests are too small, constrictive binding is ineffective as the guest molecules pass through the portals; if the guests are too large, the energy barrier becomes too high, preventing complexation from occurring [
70,
71]. Both guest shape and size influence the observed constrictive binding [
72]. As a result, the in-and-out kinetics of the guest depend on the cage’s conformation and are also correlated with the cage–guest affinity, where stronger affinity leads to slower kinetics [
73]. The binding properties in these guest⊂cage complexes can be described as the combination of intrinsic binding (i.e., free energy difference between the complex and free cage and guest) and the constrictive binding as the additional free energy barrier associated with the guest passing through the portals of the cage (
Figure 1) [75]. These systems, in which the guest molecule is trapped inside the cage, and it is only released from it under specific conditions, act as a gating mechanism as described by Houk [
74,
75,
76,
77,
78].
Metallo-organic cages have the same host–guest behaviour as organic cages. Fujita and his team have shown a “ship in a bottle” entrapment-type synthesis showing that a large labile cyclic silanol, that fits tightly to the cage cavity, prevents its hydrolysis for more than one month [
79]. This shows the feasibility of using molecular cages to effectively isolate the encapsulated guest from the surrounding media, highlighting the importance of having a large enough sized guest that cannot pass through the portals of the host. If the size of the guest is smaller than the portal, Raymond showed that the partial dissociation of the host structure can create a portal for in–out guest passage, and the deformation of the host structure can create a dilated aperture for guest passage without any host rupture [
80].
Nitschke and his team measured the rate constant for guest uptake (
kin) and the association constant (
KAss) for Nitschke’s water-soluble Fe
4L
6 metal–organic cage. We have carefully reanalyzed this data and determined guest release rate constants (
kout) as
kout=
kin/
KAss, showing a guest release decrease with guest size. On one side, the guest must have a smaller size than the cavity size (150 Å
3) as guests with a size of 135 Å
3 or larger do not bind. For smaller guests, the
kout decreases with the size of the guest, from 5 ×10
–2 s
–1 for acetone (73 Å
3) to 5 ×10
–8 s
–1 for cyclohexane (111 Å
3). These results show an impressive change of 6 orders of magnitude in the
out-rate, changing the release timescale from seconds to months, from the smaller to the larger guest [
81].
In this work, we study the thermodynamic and kinetic requirements of guest⊂cage complexes for drug delivery applications. We focus on both, dynamic and constrictive binding systems, analyzing the effects of dilution, binding constant strength, and the activation energy required for the encapsulated guest to escape the cavity of the cage in operational systems.